We are live on ! Find out more
CAM

Cormorant Asset Management Portfolio holdings

AUM $1.99B
1-Year Est. Return 737.95%
This Fund
S&P 500
This Quarter Est. Return
+35.53%
1 Year Est. Return
+737.95%
3 Year Est. Return
+5,256.52%
5 Year Est. Return
+13,483.26%
10 Year Est. Return
+564,575.55%
AUM
$1.48B
AUM Growth
+$248M
Cap. Flow
-$58.8M
Cap. Flow %
-3.97%
Top 10 Hldgs %
45.09%
Holding
80
New
10
Increased
13
Reduced
36
Closed
16

Top Buys

Rank Stock Value
1
IFRX icon
InflaRx
IFRX
+$41.5M
2
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$30.2M
3
CCXI
ChemoCentryx, Inc.
CCXI
+$28.9M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$27.7M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$27M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$66.8M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$46M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$37.2M
4
TBPH icon
Theravance Biopharma
TBPH
+$22.6M
5
ARGX icon
argenx
ARGX
+$20.6M

Sector Composition

Rank Sector Weight
1 Healthcare 91.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFRX
76
DELISTED
ContraFect Corporation
CFRX
– –
-3,632
Closed -$4.45M
ARQL
77
DELISTED
Arqule Inc
ARQL
– –
-292,095
Closed -$809K
TSRO
78
CALL
DELISTED
TESARO, Inc.
TSRO
– –
-1,253,300
Closed -$93.1M
TSRO
79
DELISTED
TESARO, Inc.
TSRO
– –
-900,000
Closed -$66.8M
ZGNX
80
CALL
DELISTED
Zogenix, Inc.
ZGNX
– –
-250,000
Closed -$9.12M
1 2 3
4

Similar funds

SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

Cormorant Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Cormorant Asset Management held 80 positions worth $1.48B, up 20% from $1.23B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Cormorant Asset Management withdrew a net $58.8M in Q1 2019, closing 16 positions and reducing 36 holdings. Its most notable exit was TESARO, Inc., an estimated $66.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 86% a quarter earlier.

Against the trend, Cormorant Asset Management opened a new position in Lakefront Biotherapeutics American Depositary Shares worth $35M.

  • Cormorant Asset Management's largest Q1 2019 buy was Lakefront Biotherapeutics American Depositary Shares: 300,000 shares worth $35M.
  • Cormorant Asset Management added most to InflaRx in Q1 2019, an estimated $41.5M increase.
  • Cormorant Asset Management's biggest Q1 2019 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $46M.
  • Cormorant Asset Management fully exited TESARO, Inc. in Q1 2019, selling an estimated $66.8M.
  • Cormorant Asset Management's ten largest holdings make up 45% of its $1.48B portfolio in Q1 2019.
  • Cormorant Asset Management opened 10 new positions and closed 16 in Q1 2019.
  • Cormorant Asset Management's portfolio value rose 20% quarter-over-quarter to $1.48B.

Based on Cormorant Asset Management's 13F filing for Q1 2019, filed 15 May 2019.